Intra-Cellular Therapies, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/09/2025 | 9.52 M | $1.26 B | -2.07% | 9.23% |
| PENTWATER CAPITAL MANAGEMENT LP | 05/15/2025 | 5.19 M | $684.66 M | 100.00% | 5.03% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 05/15/2025 | 3.49 M | $459.75 M | 100.00% | 3.38% |
| UBS OCONNOR LLC | 05/15/2025 | 3.09 M | $407.78 M | 15,139.27% | 3.00% |
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2025 | 3.06 M | $403.02 M | 100.00% | 2.96% |
| FMR LLC | 05/12/2025 | 2.66 M | $351.21 M | -75.96% | 2.58% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 2.26 M | $297.86 M | 1,516.72% | 2.19% |
| CITADEL ADVISORS LLC | 05/15/2025 | 2.24 M | $295.12 M | 1,795.54% | 2.17% |
| DEEP TRACK CAPITAL, LP | 05/15/2025 | 2.00 M | $263.84 M | 0.00% | 1.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.83 M | $241.74 M | 6.71% | 1.78% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.82 M | $239.47 M | 398.20% | 1.76% |
| STATE STREET CORP | 05/15/2025 | 1.78 M | $234.99 M | -4.99% | 1.73% |
| WEISS ASSET MANAGEMENT LP | 05/15/2025 | 1.64 M | $216.35 M | 100.00% | 1.59% |
| GLAZER CAPITAL, LLC | 05/15/2025 | 1.58 M | $208.39 M | 100.00% | 1.53% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 1.47 M | $194.42 M | 291.52% | 1.43% |
| MORGAN STANLEY | 05/15/2025 | 1.40 M | $185.14 M | 57.26% | 1.36% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 1.09 M | $144.29 M | 100.00% | 1.06% |
| TIG ADVISORS, LLC | 05/15/2025 | 1.06 M | $139.56 M | 100.00% | 1.03% |
| LMR PARTNERS LLP | 05/15/2025 | 991.10 K | $130.75 M | 100.00% | 0.96% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 931.33 K | $122.86 M | 267.10% | 0.90% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 923.81 K | $121.87 M | 72.85% | 0.90% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 895.66 K | $118.16 M | -1.21% | 0.87% |
| LMR PARTNERS LLP | 05/15/2025 | 863.13 K | $113.86 M | 10,455.63% | 0.84% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 844.07 K | $111.35 M | 62.06% | 0.82% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 786.36 K | $103.74 M | -38.96% | 0.76% |
| JPMORGAN CHASE & CO | 05/12/2025 | 759.99 K | $100.26 M | -85.17% | 0.74% |
| KRYGER CAPITAL LTD | 05/15/2025 | 750.57 K | $99.02 M | 100.00% | 0.73% |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 05/15/2025 | 719.55 K | $94.92 M | 100.00% | 0.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 700.90 K | $92.46 M | -51.29% | 0.68% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 693.43 K | $91.48 M | -10.64% | 0.67% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 05/15/2025 | 691.28 K | $91.19 M | 100.00% | 0.67% |
| NORTHERN TRUST CORP | 05/13/2025 | 634.54 K | $83.71 M | 4.06% | 0.62% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 625.00 K | $82.45 M | -79.51% | 0.61% |
| TUDOR INVESTMENT CORP ET AL | 05/15/2025 | 621.82 K | $82.03 M | 100.00% | 0.60% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 621.20 K | $81.95 M | 97.52% | 0.60% |
| MAN GROUP PLC | 05/15/2025 | 620.70 K | $81.88 M | 1,177.24% | 0.60% |
| FIL LTD | 05/12/2025 | 568.00 K | $74.93 M | 100.00% | 0.55% |
| AMUNDI | 05/15/2025 | 561.27 K | $74.01 M | 20,466.73% | 0.54% |
| BERYL CAPITAL MANAGEMENT LLC | 05/15/2025 | 541.64 K | $71.45 B | 100.00% | 0.53% |
| LMR PARTNERS LLP | 05/15/2025 | 450.00 K | $59.36 M | 100.00% | 0.44% |
| TACONIC CAPITAL ADVISORS LP | 05/15/2025 | 443.70 K | $58.53 M | 100.00% | 0.43% |
| TWIN SECURITIES, INC. | 05/15/2025 | 440.69 K | $58.14 M | 100.00% | 0.43% |
| MARSHALL WACE, LLP | 05/15/2025 | 440.67 K | $58.13 M | -59.19% | 0.43% |
| MAGNETAR FINANCIAL LLC | 05/15/2025 | 435.72 K | $57.48 M | 100.00% | 0.42% |
| MELQART ASSET MANAGEMENT (UK) LTD | 05/15/2025 | 400.70 K | $52.86 M | 100.00% | 0.39% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 382.23 K | $50.42 M | 1,760.92% | 0.37% |
| GOVERNORS LANE LP | 05/15/2025 | 377.74 K | $49.83 B | 100.00% | 0.37% |
| ING GROEP NV | 05/09/2025 | 376.80 K | $49.71 M | 2,914.40% | 0.37% |
| PICTON MAHONEY ASSET MANAGEMENT | 05/07/2025 | 365.00 K | $48.15 M | 506,844.44% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 350.04 K | $46.18 M | -2.51% | 0.34% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intra-Cellular Therapies, Inc. institutional Ownership - FAQ's
During the previous two years, 398 institutional investors and hedge funds held shares of Intra-Cellular Therapies, Inc.. The most heavily invested institutionals were:
Pentwater Capital Management LP: 5.19 M
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP: 3.49 M
UBS OCONNOR LLC: 3.09 M
FARALLON CAPITAL MANAGEMENT LLC: 3.06 M
BALYASNY ASSET MANAGEMENT L.P.: 2.26 M
Deep Track Capital, LP: 2 M
14.68% of Intra-Cellular Therapies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.64 M shares in the last 24 months. This purchase volume represents approximately $9.31 B in transactions.